Antenatal treatment of fetal alloimmune thrombocytopenia: a current perspective.
作者信息
Vinograd Cheryl A, Bussel James B
出版信息
Haematologica. 2010 Nov;95(11):1807-11. doi: 10.3324/haematol.2010.030148.
Abstract
摘要
相似文献
1
Antenatal treatment of fetal alloimmune thrombocytopenia: a current perspective.
Haematologica. 2010 Nov;95(11):1807-11. doi: 10.3324/haematol.2010.030148.
2
Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobulin infusion.
Haematologica. 2010 Nov;95(11):1921-6. doi: 10.3324/haematol.2010.025106. Epub 2010 Jun 9.
3
Repeated intrauterine IgG infusions in foetal alloimmune thrombocytopenia do not increase foetal platelet counts.
Vox Sang. 2010 Nov;99(4):348-53. doi: 10.1111/j.1423-0410.2010.01367.x.
4
Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia.
Am J Obstet Gynecol. 2016 Oct;215(4):471.e1-9. doi: 10.1016/j.ajog.2016.04.033. Epub 2016 Apr 27.
5
Neonatal outcome in alloimmune thrombocytopenia after maternal treatment with intravenous immunoglobulin.
Blood Transfus. 2015 Jan;13(1):66-71. doi: 10.2450/2014.0309-13. Epub 2014 Jun 19.
6
Contemporary management of neonatal alloimmune thrombocytopenia: good outcomes in the intravenous immunoglobulin era: results from the Australian neonatal alloimmune thrombocytopenia registry.
J Matern Fetal Neonatal Med. 2017 Oct;30(20):2488-2494. doi: 10.1080/14767058.2016.1253064. Epub 2016 Nov 24.
7
New developments in fetal and neonatal alloimmune thrombocytopenia.
Am J Obstet Gynecol. 2021 Aug;225(2):120-127. doi: 10.1016/j.ajog.2021.04.211. Epub 2021 Apr 8.
8
Neonatal alloimmune thrombocytopenia: antenatal management.
Am J Obstet Gynecol. 2000 May;182(5):1233-8. doi: 10.1067/mob.2000.104841.
9
Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia.
Transfusion. 2016 Oct;56(10):2449-2454. doi: 10.1111/trf.13779. Epub 2016 Sep 9.
10
Low-Dose versus Standard-Dose Intravenous Immunoglobulin to Prevent Fetal Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia: A Randomized Trial.
Fetal Diagn Ther. 2015;38(2):147-53. doi: 10.1159/000380907. Epub 2015 Apr 17.
引用本文的文献
1
Neonatal Immune Incompatibilities between Newborn and Mother.
J Clin Med. 2020 May 14;9(5):1470. doi: 10.3390/jcm9051470.
2
Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities.
Int J Womens Health. 2017 Apr 19;9:223-234. doi: 10.2147/IJWH.S90753. eCollection 2017.
3
Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia.
Genes Dis. 2015 Jun 1;2(2):173-185. doi: 10.1016/j.gendis.2015.02.003.
4
Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies.
Blood. 2015 Sep 3;126(10):1234-6. doi: 10.1182/blood-2014-11-611020. Epub 2015 Jul 24.
5
Successful management of neonatal alloimmune thrombocytopenia in the second pregnancy: a case report.
Einstein (Sao Paulo). 2014 Jan-Mar;12(1):96-9. doi: 10.1590/s1679-45082014rc2729.
6
Fetal and neonatal alloimmune thrombocytopenia.
Rev Obstet Gynecol. 2013;6(1):e15-21.
7
Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers.
Blood. 2013 Jul 18;122(3):313-20. doi: 10.1182/blood-2013-02-481887. Epub 2013 May 8.
8
Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.
Blood. 2013 Jul 18;122(3):321-7. doi: 10.1182/blood-2012-11-468561. Epub 2013 May 3.
本文引用的文献
1
Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobulin infusion.
Haematologica. 2010 Nov;95(11):1921-6. doi: 10.3324/haematol.2010.025106. Epub 2010 Jun 9.
2
Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus.
Am J Obstet Gynecol. 2010 Aug;203(2):135.e1-14. doi: 10.1016/j.ajog.2010.03.011. Epub 2010 May 21.
3
Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial.
Obstet Gynecol. 2007 Aug;110(2 Pt 1):249-55. doi: 10.1097/01.AOG.0000270302.80336.dd.
4
Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective.
BJOG. 2007 Apr;114(4):469-73. doi: 10.1111/j.1471-0528.2007.01244.x. Epub 2007 Feb 19.
5
Antenatal noninvasive treatment of patients at risk for alloimmune thrombocytopenia without a history of intracranial hemorrhage.
Am J Obstet Gynecol. 2006 Oct;195(4):1153-7. doi: 10.1016/j.ajog.2006.06.066.
6
Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia.
Obstet Gynecol. 2006 Jan;107(1):91-6. doi: 10.1097/01.AOG.0000192404.25780.68.
7
Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia.
Pediatr Blood Cancer. 2005 Aug;45(2):176-83. doi: 10.1002/pbc.20282.
8
Antenatal interventions for fetomaternal alloimmune thrombocytopenia.
Cochrane Database Syst Rev. 2005 Jan 25(1):CD004226. doi: 10.1002/14651858.CD004226.pub2.
9
Management of fetal alloimmune thrombocytopenia-a less invasive option?
J Obstet Gynaecol. 1999 Mar;19(2):119-21. doi: 10.1080/01443619965372.
10
PLATELET AND LEUKOCYTE ISOANTIGENS AND THEIR ANTIBODIES: SEROLOGIC PHYSIOLOGIC AND CLINICAL STUDIES.
Prog Hematol. 1964;4:222-304.
Zotero 插件